论文信息 - A phase I study of SAR566658, an anti CA6-antibody drug conjugate (ADC), in patients (Pts) with CA6-positive advanced solid tumors (STs)(NCT01156870). - 字舞流文

A phase I study of SAR566658, an anti CA6-antibody drug conjugate (ADC), in patients (Pts) with CA6-positive advanced solid tumors (STs)(NCT01156870).

A. Tolcher | K. Papadopoulos | V. Moreno | V. Boni | E. Calvo | J. Delord | C. Gomez-Roca | O. Rixe | P. Cohen | S. Ziti-Ljajic | A. Tellier | J. Morris